ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

58
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullish•Pacific Edge
•14 Oct 2020 06:44

S&P/NZX 50 Index Rebalance: Pacific Edge IN With A Lot to Buy

Ad hoc changes have been announced to the S&P/NZX50 index following APVG's acquisition of Metlifecare. The real impact is on Pacific Edge, the...

Logo
446 Views
Share
bullish•Pacific Edge
•20 Jul 2020 15:32•Issuer-paid

Pacific Edge - CMS reimbursement obtained

Pacific Edge announced that it has successfully gained inclusion into a local coverage determination (LCD) enabling reimbursement at US$760 per...

Share
bullish•Pacific Edge
•14 Jul 2020 08:07•Broker

Pacific Edge: Patience Pays Off

Pacific Edge Patience Pays Off RESEARCH INSIGHTS Pacific Edge (PEB) has ticked off two major milestones in recent weeks, which should support a...

Logo
220 Views
Share
bullish•Pacific Edge
•09 Jun 2020 08:01•Broker

Pacific Edge: FY20 Result — No Change in the Script

Pacific Edge FY20 Result — No Change in the Script RESEARCH INSIGHTS Pacific Edge's (PEB) FY20 result provided little in the way of new...

Logo
200 Views
Share
bullish•Pacific Edge
•02 Jun 2020 08:25•Broker

Pacific Edge: A Game of Patience

Pacific Edge A Game of Patience RESEARCH INSIGHTS We lower our near-term revenue expectations for Pacific Edge (PEB) ahead of the upcoming FY20...

Logo
204 Views
Share
x